The discussion encompassing the clinical meaning of leftover stone pieces after ureteroscopic lithotripsy has acquired expanding consideration lately. This is to a limited extent because of the amassing of proof proposing that even little lingering pieces (under 4 mm) can go about as a nidus for future stone arrangement and can prompt expanded horribleness and reoperation rates.1,2 Importantly, the new spotlight on leftover parts has revolved around clinical dangers, advantages and results of the different administration choice pathways, however has neglected to join the expense of treatment or cost-viability. With proceeded with accentuation on improvement of medical services assets in the current medical care environment, limiting pointless strategies will have a basic part in the expense adequacy of a given therapy pathway. In particular, in the United States the Medicare Access and CHIP Reauthorization Act of 2015 (ordinarily known as MACRA) is gradually eliminating the charge for-administration model that has been a pillar of medical services installment for esteem based reimbursement.3 We contrasted the expense viability of perception with that of quick reintervention for asymptomatic leftover pieces after ureteroscopic lithotripsy.

Reference link-